# A Two-Week Study of the Efficacy and Safety of Mifepristone in the Prevention of Olanzapine-Induced Weight Gain

> **NCT00455442** · PHASE2 · COMPLETED · sponsor: **Corcept Therapeutics** · enrollment: 57 (actual)

## Conditions studied

- Weight-Gain Prevention

## Interventions

- **DRUG:** Mifepristone

## Key facts

- **NCT ID:** NCT00455442
- **Lead sponsor:** Corcept Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2008-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00455442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00455442, "A Two-Week Study of the Efficacy and Safety of Mifepristone in the Prevention of Olanzapine-Induced Weight Gain". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00455442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*